News

Relapse occurred in 39% of the maintenance group, compared to 56% in the discontinuation group.

Investigators call for pollen monitoring that provides free, continuous, real‐time pollen data representative for any given region.

Factors associated with decreased receipt of ophthalmic telehealth care included older age, male sex, and patients with an educational level of high school or less.

Serious infections occurred in less than 2% of patients treated with the medication during the duration of the 52-week trial.

Delgocitinib is the first and only topical JAK/STAT pathway inhibitor in Japan, and recent data suggests it is effective in the management of atopic dermatitis.

Tramadol is examined alongside codeine to determine if it puts patients at a higher risk of adverse cardiovascular events.

Dr. Lawrence Eichenfield and Dr. David Rosmarin speak to the efficacy of topical ruxolitinib displayed in several trials involving patients with atopic dermatitis and vitiligo.

An unplanned pregnancy can translate into a multitude of health factors and risks for both the mother and the baby.

Investigators also found that patients with alopecia areata were also had significant inflammatory immune injury and vitamin D deficiency when compared to healthy subjects.

Diabetes progression included greater likelihood of insulin treatment initiation, hyperglycemia, glycemic complications, and glucose-lowering prescriptions.

Just 7% of patients in the BPA group suffered a recurrent CDI episode within 14-56 days of initiating treatment.

Investigators noted the relationship of reading performance with visual acuity supports the validity of reading performance as end point in clinical trials.

Taste scores were significantly correlated with depression scores for both patients with irritable bowel syndrome and functional constipation.

The ongoing PIANO registry is designed to keep real time data on the outcomes of pregnant patients with IBD.

Dr. Paller speaks of the AD-GAP study, which shared insights on moderate to severe atopic dermatitis from patients, caregivers, and independent physicians.

Episode 3 of Crisis Point examines the regional differences in obesity, from issues with nutrition and food insecurity to the use of the phrase "food desert".

Investigators also reported an increase in individualized FeNO associated with young female patients.

Data show SGLT2 inhibitor therapy, in comparison to GLP-1 RA therapy, was associated with slightly lower risk for myocardial infarction (MI) or stroke in patients with CVD.

Investigators incorporated a myriad of studies detailing the anxiety and depression associated with the disease, and offered new insights into the concerns of patients and caregivers.

A recent press release detailed the phase 3 findings that were presented at the virtual conference, which shows that bimekizumab was well-tolerated and efficacious in patients with moderate to severe plaque psoriasis.

Clinicians identified key strategies that could improve the challenge of treating lower back pain in emergency departments.

In research presented virtually at IDWeek 2021, investigators with the US Centers for Disease Control and Prevention conducted a review of nursing home antibiotic stewardship citation deficiencies in order to improve implementation.

Data from 5 trials presented at ID Week 2021 are promising for the investigational biotherapeutic.

Adult patients with moderate-to-severe atopic dermatitis reported incremental improvement of their condition in a new extension trial study presented at EADV.

Data show the 20-year cumulative incidence of AVR was 3.4% in mild AS, 20.2% in moderate AS, and 54.6% in severe AS.

Risky sexual behavior is the sole independent predictor of acute HDV.

Investigators reported that the vaccine prevented symptomatic and severe cases of COVID-19 in several populations including older patients.

Montefiore experts discuss the emphasis on education at their MFM-Cardiology care program.

Age, antibiotic use, and proton pump inhibitor use was associated with an increase in C difficile infections.

Maralixibat oral solution is indicated for the treatment of cholestatic pruritus in patients with Alagille syndrome.